This grant is for the purpose of funding highly innovative, untested, and potentially high-gain concepts or methods addressing critical problems in prostate cancer. The DoD’s Prostate Cancer Research Program (PCRP) offers this award to help investigators pursue novel observations that may lead to new avenues of research or provide initial proof-of-principle for innovative hypotheses. Projects should align with PCRP’s overarching challenges or demonstrate a significant need in prostate cancer research or patient care. This award supports preliminary investigations; extensive preliminary data is discouraged. Proposals involving human subjects or specimens must qualify for exempt or expedited review.
Opportunity ID: 89253
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-11-PCRP-EHDA |
| Funding Opportunity Title: | DoD FY11 Prostate Cancer Exploration-Hypothesis Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 30 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 21, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 08, 2011 |
| Current Closing Date for Applications: | Jun 08, 2011 |
| Archive Date: | Jul 08, 2011 |
| Estimated Total Program Funding: | $3,600,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PCRP Exploration � Hypothesis Development Award mechanism was first offered in FY03. Since then, 1,056 Exploration � Hypothesis Development Award applications have been received, and 142 have been recommended for funding. The Exploration � Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based, or initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Presentation of preliminary data is strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be provided. All applications for the Exploration � Hypothesis Development Award are highly recommended to address one of the FY11 PCRP overarching challenges. The PCRP seeks to fund projects from the wide spectrum of basic to clinical research; however, if the proposed project does not address one of the overarching challenges, the application should provide a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. Because these awards are designed for preliminary investigations, projects involving human subjects or specimens will not be supported unless they are exempt under 32 CFR 219.101(b) or eligible for expedited review (32 CFR 219.110 or 21 CFR 56.110). Additional information on the protection of human subjects and exempt or expedited review status may be found at https://www.bids.tswg.gov/. Also, for more information on clinical research, a Human Subject Resource Document is provided at https://cdmrp.org/Program_Announcements_and_Forms/. Applications proposing studies that do not qualify for exempt or expedited review status will be administratively withdrawn. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 89253 Full Announcement-1 -> pcrp_fy11_ehda_ pa_gg .pdf
Packages
| Agency Contact Information: | 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00049571 | Apr 21, 2011 | Jun 08, 2011 | View |
Package 1
Mandatory forms
89253 RR_SF424_1_2-1.2.pdf
89253 PerformanceSite_1_4-1.4.pdf
89253 RR_Budget-1.1.pdf
89253 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
89253 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
